Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Filings indexed 1,715 across all filing types
Latest filing 2024-12-15 Proxy Solicitation & In…
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业(集团)股份有限公司关于召开2024年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2024 second extraordinary general meeting of shareholders (临时股东大会) for the company 金花企业(集团)股份有限公司. It details the meeting date, voting methods, agenda items, registration procedures, and proxy authorization. There is no financial data, earnings, or report content included. The document serves as an announcement to shareholders about the meeting logistics and agenda, not the meeting minutes or voting results. This fits the category of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to solicit votes for meetings.
2024-12-15 Chinese
金花企业(集团)股份有限公司第十届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the 10th Board of Directors of Jinhua Enterprise (Group) Co., Ltd. It includes details about the meeting date, voting results, and references to related announcements and shareholder meetings. The content focuses on board decisions and meeting outcomes rather than full financial reports or detailed management discussions. It is not a full Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or a report publication announcement. The document fits the category of Board/Management Information (MANG) as it announces board meeting resolutions and related corporate governance matters.
2024-12-15 Chinese
金花企业(集团)股份有限公司关于签订股权转让协议之补充协议(二)暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding a supplemental agreement to a share transfer agreement involving a related party transaction. It includes information about the transaction terms, approval processes by the board and independent directors, and the need for shareholder approval. The document is a formal announcement of a corporate transaction and related governance procedures, not a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data but focuses on the disclosure of a related party transaction and its approval process. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-12-15 Chinese
金花企业(集团)股份有限公司2024年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2024 Second Extraordinary General Meeting of Shareholders" of 金花企业(集团)股份有限公司. It contains the meeting agenda, details about the meeting format, time, location, and a specific proposal regarding a supplementary agreement to a share transfer agreement. The content is focused on the meeting logistics and the proposal to be voted on, rather than the results of the vote or a report of the meeting outcome. The document length is 2873 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no indication that this is a voting results announcement or a report publication announcement. The document fits the description of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. Therefore, the classification is AGM-R with high confidence.
2024-12-15 Chinese
金花企业(集团)股份有限公司关于使用部分闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's decision to use part of its idle raised funds temporarily to supplement working capital. It details the amount, usage period, previous usage and repayment of such funds, and includes approvals from the board and supervisory committee. It references regulatory approvals and compliance with relevant guidelines. The document is a formal announcement about the use of raised capital funds, not a full financial report or audit. It is not a report publication announcement since it contains substantive details about the usage plan and approvals. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-12-05 Chinese
国金证券股份有限公司关于金花企业(集团)股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from Guojin Securities regarding the use of idle raised funds by Jinhua Enterprise (Group) Co., Ltd. It references regulatory guidelines, specific board and supervisory meetings approving the use of idle raised funds to temporarily supplement working capital, and the compliance with relevant laws and regulations. The document includes detailed financial figures about the raised funds, their usage, and repayment timelines. It is not a full annual or interim financial report but rather a regulatory compliance and verification statement related to the use of raised funds. The document length is 3760 characters, which is relatively short but contains substantive content about the use of funds and regulatory compliance, not merely an announcement or certification. This fits best under the category of Regulatory Filings (RNS), as it is a compliance-related disclosure and verification opinion rather than a full financial report or announcement of a report.
2024-12-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.